Cytogenetic Technology

Program Director
Jun Gu, M.D., Ph.D.

Associate Program Director
Ming Zhao, M.D.

The Cytogenetic Technology program is accredited by and has conformed its curriculum to the standards published and monitored by the:

National Accrediting Agency for Clinical Laboratory Sciences (NAACLS)
5600 N. River Rd., Ste. 720
Rosemont, IL 60018-5119
Phone   773-714-8880
Fax   773-714-8886

The program has developed affiliations with reference labs and medical institutions across the United States, so that students will develop expertise in a variety of settings and experience the breadth of opportunity available to a certified cytogenetic technologist. During the clinical phase of instruction, training and supervision are provided in affiliated clinical laboratories.

Houston

• MD Anderson Department of Hematopathology, Cytogenetics Section 
• Baylor Genetics 
  
• NeoGenomics Laboratories 
• Texas Children's Hospital

Texas

• CorePath Laboratories, San Antonio
  
• Quest Diagnostics | med fusion, Lewisville
  
• ProPath, Dallas
• The University of Texas Southwestern Medical Center, Dallas

LABORATORY INTERNSHIP PLACEMENT POLICY

Purpose

The purpose of this policy is to outline the process by which a student enrolled in the Cytogenetic Technology Program is informed and affected by a laboratory internship rotation cancellation.

Policy Statement

It is the policy of The University of Texas MD Anderson Cancer Center School of Health Professions Program in Cytogenetic Technology to limit student enrollment to that of available laboratory internship rotations. In case of an internship rotation site cancellation, affected student/s must be informed within 5 school days of the cancellation. Student placement in the remaining laboratory internship rotation will be picked up by one of the MD Anderson rotation sites; or an equitable experience will be offered in the program’s student laboratory; or by other Houston sites to ensure their clinical education will not be interrupted.

Clinical cytogenetics is the specialty that studies cell division and the structure of chromosomes as applied to the diagnosis and monitoring of acquired and inherited abnormalities.

The most widely recognized use of cytogenetics is the study of inherited disorders through prenatal diagnosis by amniocentesis and chorionic villus sampling or postnatal diagnosis by peripheral blood studies. Cytogenetic technology is also used in the study of acquired chromosomal abnormalities present in various forms of cancer.

In recent years the Human Genome Project has greatly affected genetic testing at all levels. The discovery of new genes and the identification of the DNA sequence and location of diagnostically relevant genes have lead to the development of the new field of molecular cytogenetics.

It is now widely accepted that most human disease is caused in part by a genetic defect. Identification of these genetic abnormalities has become an essential part in the medical treatment of patients in many specialty institutions across the country.

The primary responsibility of the clinical cytogenetic technologist is the analysis and karyotyping of human chromosome preparations. The clinical genetics technologist must be able to perform all aspects of the cytogenetic procedure. Cytogenetics requires a basic understanding of cell culture and the cell growth cycle, the biochemistry of staining procedures, microscopy, computer imaging and new techniques in molecular cytogenetics.

As a member of the health care team, a cytogenetic technologist uses a strong background in the sciences to do cytogenetic analysis, a crucial step in the diagnosis, prognosis, treatment and follow-up of genetic disorders. Cytogenetic results may also indicate that genetic counseling is required for family members other than the patient.

According to the salary survey conducted by the Department of Academic Affairs at MD Anderson Cancer Center, the average starting salary for a staff cytogenetic technologist is $45,000 to $55,000.